327 related articles for article (PubMed ID: 7884853)
1. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.
Palladino G; Mozdzanowska K; Washko G; Gerhard W
J Virol; 1995 Apr; 69(4):2075-81. PubMed ID: 7884853
[TBL] [Abstract][Full Text] [Related]
2. Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.
Mozdzanowska K; Feng J; Gerhard W
J Virol; 2003 Aug; 77(15):8322-8. PubMed ID: 12857901
[TBL] [Abstract][Full Text] [Related]
3. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro.
Mozdzanowska K; Furchner M; Washko G; Mozdzanowski J; Gerhard W
J Virol; 1997 Jun; 71(6):4347-55. PubMed ID: 9151823
[TBL] [Abstract][Full Text] [Related]
4. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.
Feng JQ; Mozdzanowska K; Gerhard W
J Virol; 2002 Feb; 76(3):1369-78. PubMed ID: 11773411
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
Dhein J; Daniel PT; Trauth BC; Oehm A; Möller P; Krammer PH
J Immunol; 1992 Nov; 149(10):3166-73. PubMed ID: 1431095
[TBL] [Abstract][Full Text] [Related]
6. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
[TBL] [Abstract][Full Text] [Related]
7. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.
Tamura S; Funato H; Hirabayashi Y; Kikuta K; Suzuki Y; Nagamine T; Aizawa C; Nakagawa M; Kurata T
Vaccine; 1990 Oct; 8(5):479-85. PubMed ID: 2251874
[TBL] [Abstract][Full Text] [Related]
8. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
Schlesinger JJ; Foltzer M; Chapman S
Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
[TBL] [Abstract][Full Text] [Related]
9. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice.
Dobber R; Tielemans M; Nagelkerken L
Cell Immunol; 1995 Feb; 160(2):185-92. PubMed ID: 7720078
[TBL] [Abstract][Full Text] [Related]
10. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
Mozdzanowska K; Maiese K; Furchner M; Gerhard W
Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
12. Role of the B-cell response in recovery of mice from primary influenza virus infection.
Gerhard W; Mozdzanowska K; Furchner M; Washko G; Maiese K
Immunol Rev; 1997 Oct; 159():95-103. PubMed ID: 9416505
[TBL] [Abstract][Full Text] [Related]
13.
Van den Hoecke S; Ballegeer M; Vrancken B; Deng L; Job ER; Roose K; Schepens B; Van Hoecke L; Lemey P; Saelens X
mBio; 2021 Aug; 12(4):e0074521. PubMed ID: 34253060
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
Schlesinger JJ; Chapman S
J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
[TBL] [Abstract][Full Text] [Related]
15. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
Renegar KB; Small PA; Boykins LG; Wright PF
J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
Muramatsu M; Yoshida R; Yokoyama A; Miyamoto H; Kajihara M; Maruyama J; Nao N; Manzoor R; Takada A
PLoS One; 2014; 9(1):e85582. PubMed ID: 24465606
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice.
Van Snick JL; Coulie P
J Exp Med; 1982 Jan; 155(1):219-30. PubMed ID: 6976413
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing Antibodies Induced by Gene-Based Hydrodynamic Injection Have a Therapeutic Effect in Lethal Influenza Infection.
Yamazaki T; Nagashima M; Ninomiya D; Ainai A; Fujimoto A; Ichimonji I; Takagi H; Morita N; Murotani K; Hasegawa H; Chiba J; Akashi-Takamura S
Front Immunol; 2018; 9():47. PubMed ID: 29416543
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
Peterson EM; Cheng X; Motin VL; de la Maza LM
Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
